UPDATE: Goldman Sachs Assumes Centessa Pharmaceuticals (CNTA) at Neutral
Tweet Send to a Friend
(Updated - February 11, 2022 4:30 AM EST)
Goldman Sachs analyst Andrea Tan assumes coverage on Centessa Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Andrea Tan assumes coverage on Centessa Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
